NASDAQ:BLU (Bellus Health)
About BLU
BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.
Bellus Health (NASDAQ: BLU) Latest News
Metals and Mining Stocks
TSX Today: Why Canadian Stocks Could Rally on Wednesday, February 8
Investing
2 Best Healthcare Stocks to Buy Right Now
Investing
2 Top Healthcare Stocks Defying the Bear Market
Investing
3 Growth Stocks up Over 50% in 2022
Investing
Parabolic Returns in 2022 Are Possible From 3 Growth Stocks
Metals and Mining Stocks
TSX Today: What to Watch for in Stocks on Tuesday, December 14
Coronavirus
Why BELLUS Health Exploded 60% on Monday
Stocks for Beginners
2 Canadian Healthcare Stocks That Are All-Stars in the Making
Stocks for Beginners
4 Canadian Stocks That Could Soar 68% or More According to Bay Street
Investing
Why BELLUS Health (TSX:BLU) Stock Jumped 30% on the TSX Today!
Energy Stocks
3 Bargain TSX Stocks to Buy While They’re Low
Cannabis Stocks
3 Top Growth Stocks to Own Before They Take Off
1❯